INVA Innoviva Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INVA

Price (delayed)

$15.04

Market cap

$1.05B

P/E Ratio

5.88

Dividend/share

N/A

EPS

$2.56

Enterprise value

$1.37B

Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.

Highlights
The revenue has grown by 15% YoY
The gross profit is up by 15% YoY
The company's EPS fell by 21% QoQ but it rose by 2.4% YoY
The stock's price to earnings (P/E) is 19% less than its 5-year quarterly average of 7.2 but 4.5% more than its last 4 quarters average of 5.6
Innoviva's quick ratio has plunged by 97% YoY and by 95% from the previous quarter
The debt has grown by 40% YoY and by 37% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.inva.com
Peers: OCUP

Key stats

What are the main financial stats of INVA
Market
Shares outstanding
69.7M
Market cap
$1.05B
Enterprise value
$1.37B
Valuations
Price to earnings (P/E)
5.88
Price to book (P/B)
2.71
Price to sales (P/S)
2.64
EV/EBIT
5.12
EV/EBITDA
4.86
EV/Sales
3.46
Earnings
Revenue
$396.41M
EBIT
$268.45M
EBITDA
$282.33M
Free cash flow
$377.8M
Per share
EPS
$2.56
Free cash flow per share
$5.43
Book value per share
$5.56
Revenue per share
$5.7
TBVPS
$14.34
Balance sheet
Total assets
$1.11B
Total liabilities
$555.26M
Debt
$542.05M
Equity
$386.64M
Working capital
$208.6M
Liquidity
Debt to equity
1.4
Current ratio
2.91
Quick ratio
2.84
Net debt/EBITDA
1.15
Margins
EBITDA margin
71.2%
Gross margin
100%
Net margin
47.3%
Operating margin
94.2%
Efficiency
Return on assets
20.2%
Return on equity
48.9%
Return on invested capital
23.4%
Return on capital employed
26.9%
Return on sales
67.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INVA stock price

How has the Innoviva stock price performed over time
Intraday
0.4%
1 week
2.1%
1 month
-2.72%
1 year
13.08%
YTD
-12.81%
QTD
-22.27%

Financial performance

How have Innoviva's revenue and profit performed over time
Revenue
$396.41M
Gross profit
$396.41M
Operating income
$373.35M
Net income
$187.5M
Gross margin
100%
Net margin
47.3%
The net margin has contracted by 36% YoY and by 30% from the previous quarter
INVA's net income is down by 29% since the previous quarter and by 26% year-on-year
The revenue has grown by 15% YoY
The gross profit is up by 15% YoY

Growth

What is Innoviva's growth rate over time

Valuation

What is Innoviva stock price valuation
P/E
5.88
P/B
2.71
P/S
2.64
EV/EBIT
5.12
EV/EBITDA
4.86
EV/Sales
3.46
The company's EPS fell by 21% QoQ but it rose by 2.4% YoY
The stock's price to earnings (P/E) is 19% less than its 5-year quarterly average of 7.2 but 4.5% more than its last 4 quarters average of 5.6
The equity has declined by 39% year-on-year and by 7% since the previous quarter
The P/B is 18% below the last 4 quarters average of 3.3
The P/S is 48% lower than the 5-year quarterly average of 5.1 and 20% lower than the last 4 quarters average of 3.3
The revenue has grown by 15% YoY

Efficiency

How efficient is Innoviva business performance
The return on invested capital has declined by 31% year-on-year and by 26% since the previous quarter
The company's return on sales fell by 31% YoY and by 27% QoQ
INVA's ROA is down by 30% from the previous quarter and by 22% YoY
INVA's return on equity is down by 18% since the previous quarter but it is up by 2.3% year-on-year

Dividends

What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INVA.

Financial health

How did Innoviva financials performed over time
The total assets is 99% greater than the total liabilities
Innoviva's quick ratio has plunged by 97% YoY and by 95% from the previous quarter
The company's current ratio has shrunk by 97% YoY and by 95% QoQ
The debt is 40% more than the equity
The debt to equity has surged by 130% year-on-year and by 47% since the previous quarter
The debt has grown by 40% YoY and by 37% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.